CA952429A - Process for the manufacture of stable poliomyelitis vaccines - Google Patents

Process for the manufacture of stable poliomyelitis vaccines

Info

Publication number
CA952429A
CA952429A CA028,989A CA28989A CA952429A CA 952429 A CA952429 A CA 952429A CA 28989 A CA28989 A CA 28989A CA 952429 A CA952429 A CA 952429A
Authority
CA
Canada
Prior art keywords
manufacture
stable
poliomyelitis vaccines
poliomyelitis
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA028,989A
Other languages
English (en)
Inventor
Rudolf Mauler
Horst Gruschkau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of CA952429A publication Critical patent/CA952429A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA028,989A 1967-09-05 1968-08-31 Process for the manufacture of stable poliomyelitis vaccines Expired CA952429A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0094296 1967-09-05

Publications (1)

Publication Number Publication Date
CA952429A true CA952429A (en) 1974-08-06

Family

ID=6987483

Family Applications (1)

Application Number Title Priority Date Filing Date
CA028,989A Expired CA952429A (en) 1967-09-05 1968-08-31 Process for the manufacture of stable poliomyelitis vaccines

Country Status (7)

Country Link
AT (1) AT281287B (de)
BE (1) BE720444A (de)
CA (1) CA952429A (de)
DK (1) DK118262B (de)
IL (1) IL30644A (de)
NL (1) NL6812467A (de)
SE (1) SE370083B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2076787A5 (en) * 1970-01-28 1971-10-15 Merieux Inst Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin

Also Published As

Publication number Publication date
AT281287B (de) 1970-05-11
IL30644A0 (en) 1968-10-24
DK118262B (da) 1970-07-27
SE370083B (de) 1974-09-30
BE720444A (de) 1969-03-05
IL30644A (en) 1973-02-28
DE1617356A1 (de) 1971-03-25
NL6812467A (de) 1969-03-07

Similar Documents

Publication Publication Date Title
CA938611A (en) Process for the preparation of n-trityl-imidazoles
CA952429A (en) Process for the manufacture of stable poliomyelitis vaccines
CA919590A (en) Process for the manufacture of thyrocalcitonin
CA765757A (en) Process for the preparation of n2f4
CA752411A (en) Process for the preparation of iminobibenzyl
CA750914A (en) Process for the manufacture of n-(5-nitro-2-furfuryliden)-1-amino-hydantoin
CA757644A (en) Process for the preparation of phosphonohalothionates
AU419842B2 (en) Process for the preparation of phenyltrichloroacetomidochlorides
CA761442A (en) Process for the preparation of oxopyrimidines
CA761444A (en) Process for the preparation of 2-amino-3-methoxypyrazine
CA769041A (en) Process for the preparation of b-lactones
AU420494B2 (en) PROCESS FOR THE PREPARATION OF b-LACTONES
CA755640A (en) Process for the preparation of 3-chlorocaprolactam
AU407489B2 (en) Process for the manufacture of 4-oxo-6-styryl tetrahedro-pyrone
AU435990B2 (en) Process for the manufacture of aryloxazoles
CA764478A (en) Process for the manufacture of nitrilo-triacetonitrile
CA751444A (en) Process for the manufacture of 4-alkyl-5-cyano-oxazoles
CA759428A (en) Process for the manufacture of a-nor-b-homo-steroids
CA766277A (en) Process for the manufacture of butine-2
CA751894A (en) Process for the manufacture of new methyl-androstenes
CA769713A (en) Process for the manufacture of new benzo-azacyclo-alkenes
CA772187A (en) Process for the preparation of adiponitrile
AU4687968A (en) PROCESS FOR THE PREPARATION OF b-LACTONES
AU2907767A (en) Process for the preparation of phenyltrichloroacetomidochlorides
AU462049B2 (en) Process for the manufacture of &-throcalcitonin and b-thyrocalcitonin